fluoxetine has been researched along with Orthomyxoviridae Infections in 1 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Orthomyxoviridae Infections: Virus diseases caused by the ORTHOMYXOVIRIDAE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pandemic outbreaks of viruses such as influenza virus or SARS-CoV-2 are associated with high morbidity and mortality and thus pose a massive threat to global health and economics." | 1.72 | 3D ( Balkema-Buschmann, A; Barth, P; Brunotte, L; de Witt, M; Faist, A; Kummer, S; Ludwig, S; Rescher, U; Schloer, S; Treuherz, D; Wälzlein, JH; Wiebe, K; Wiewrodt, R; Wunderlich, K, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schloer, S | 1 |
| Treuherz, D | 1 |
| Faist, A | 1 |
| de Witt, M | 1 |
| Wunderlich, K | 1 |
| Wiewrodt, R | 1 |
| Wiebe, K | 1 |
| Barth, P | 1 |
| Wälzlein, JH | 1 |
| Kummer, S | 1 |
| Balkema-Buschmann, A | 1 |
| Ludwig, S | 1 |
| Brunotte, L | 1 |
| Rescher, U | 1 |
1 other study available for fluoxetine and Orthomyxoviridae Infections
| Article | Year |
|---|---|
3D
Topics: Animals; Antiviral Agents; COVID-19; Fluoxetine; Humans; Influenza A virus; Influenza, Human; Interf | 2022 |